title: Chinese female breast cancer patients show a better overall survival than their male counterparts.
authors.affiliation: State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, China. xialiangping@163.com
authors.forename: Liang-ping
authors.initials: LP
authors.lastname: Xia
authors.forename: Fei-fei
authors.initials: FF
authors.lastname: Zhou
authors.forename: Gui-fang
authors.initials: GF
authors.lastname: Guo
authors.forename: Fang
authors.initials: F
authors.lastname: Wang
authors.forename: Xi
authors.initials: X
authors.lastname: Wang
authors.forename: Zhong-yu
authors.initials: ZY
authors.lastname: Yuan
authors.forename: Bei
authors.initials: B
authors.lastname: Zhang
mesh_terms: D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D018567:Breast Neoplasms, Male / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D002681:China; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D012727:Sex Characteristics; D015996:Survival Rate
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; C508053:ERBB2 protein, human